Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.004 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.078 | 0.004 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.004 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.005 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.005 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |